Medicsight partners Toshiba for Japan focus
This article was originally published in Clinica
Executive Summary
Computer-aided design (CAD) specialist Medicsight and Toshiba Medical Systems have signed a preliminary commercial agreement to make the former's MedicRead Colon and ColonCAD software available in Japan. Financials details of the collaboration were not disclosed, but London, UK-based Medicsight did say that the two companies would work towards MHLW (Ministry of Health, Labour and Welfare) approval of the technology through Toshiba's system integration subsidiary. The MedicRead Colon and ColonCAD software are designed to aid radiologists in the identification of colorectal polyps and tumours during early stages, thus enhancing the chance of successful treatment. Medicsight and Toshiba have an established relationship in the field of virtual colonoscopy, as both firms are also working together in an initiative to help radiologists and gastroenterologists use software to interpret virtual colonoscopy/CT colonography images for more detailed evaluation. Medicsight said that this initiative will also continue through 2008 and beyond.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.